MABVAX THERAPEUTICS HLDGS IN's ticker is MBVX and the CUSIP is 55414P504. A total of 15 filers reported holding MABVAX THERAPEUTICS HLDGS IN in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $19,000 | +11.8% | 26,708 | 0.0% | 0.02% | +10.5% |
| Q3 2017 | $17,000 | -54.1% | 26,708 | 0.0% | 0.02% | -68.9% |
| Q2 2017 | $37,000 | -39.3% | 26,708 | 0.0% | 0.06% | -45.0% |
| Q1 2017 | $61,000 | -32.2% | 26,708 | 0.0% | 0.11% | -40.3% |
| Q4 2016 | $90,000 | -20.4% | 26,708 | 0.0% | 0.19% | +24.0% |
| Q3 2016 | $113,000 | – | 26,708 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Biomark Capital Management Co. LLC | 26,708 | $90,000 | 0.19% |
| Delaney Dennis R | 10,000 | $34,000 | 0.07% |
| Virtu KCG Holdings LLC | 15,793 | $53,000 | 0.00% |
| Tradewinds Capital Management, LLC | 109 | $0 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 30,688 | $104,000 | 0.00% |
| DEUTSCHE BANK AG\ | 258 | $0 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 7 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1 | $0 | 0.00% |